Everon Biosciences
2010
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Grant
LATEST DEAL TYPE
$5M
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of innovative medicines intended to prevent age-related diseases. The company's medicines are prepared for selective elimination of senescent cells, enabling people to find a cure for Systemic Aging Syndrome and age-related pathologies.
Website
Formerly Known As
Tartis Aging
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 640 Ellicott Street
- Suite 444
- Buffalo, NY 14203
- United States
+1 (716) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Everon Biosciences’s full profile, request a free trial.
Everon Biosciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 06-Feb-2013 | $5M | 00.000 | Completed | Generating Revenue | |
| 2. Debt - General | 19-Aug-2011 | 00.000 | Completed | Generating Revenue | ||
| 1. Early Stage VC | 01-Jan-2010 | $3.86M | $3.86M | Completed | Generating Revenue |
Everon Biosciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Skolkovo Foundation | Limited Partner | 000 0000 | 000000 0 | |||
| Bioprocess Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
Everon Biosciences Executive Team (5)
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »